Mindfulness-based Cognitive Therapy for Patients With Functional Disorders
Primary Purpose
Somatization Disorder, Functional Disorders, Bodily Distress Disorder
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Mindfulness-Based Cognitive Therapy for Functional Disorders
Sponsored by
About this trial
This is an interventional treatment trial for Somatization Disorder focused on measuring Mindfulness-Based Cognitive Therapy, Somatization Disorder, Medically Unexplained Symptoms, Functional Somatic Symptoms, SF-36
Eligibility Criteria
Inclusion Criteria:
- Functional disorder defined as Bodily Distress Disorder, severe
- Moderate to severe impairment
- The disorder's functional component can easily be separated from a coexisting well-defined physical disease
- No lifetime-diagnosis of psychosis, bipolar affective disorder, or depression with psychotic symptoms
- Age 20-50 years
- Patients of Scandinavian origin, who understand, read, write, and speak Danish
Exclusion Criteria:
- No informed consent
- An acute psychiatric disorder demanding other treatment, or if the patient is suicidal
- Abuse of narcotics or alcohol or (non-prescribed) medicine
- Pregnancy
Sites / Locations
- Per Fink
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
No Intervention
Arm Label
A
B
Arm Description
Mindfulness-Based Cognitive Therapy
Shared care: Treatment as usual augmented by psychiatric consultation intervention to optimise treatment in the present health care system.
Outcomes
Primary Outcome Measures
Physical health measured by SF-36 Physical Component Summary
Secondary Outcome Measures
1. Social functioning, emotional disorders, coping: Sub-scales from SF-36, WHO-DAS II, CSQ, SCL, Whiteley-7, lifestyle factors, mindfulness scales. 2. Health care use: Data from national registers.
Full Information
NCT ID
NCT00497185
First Posted
July 4, 2007
Last Updated
November 11, 2011
Sponsor
University of Aarhus
Collaborators
The Ministry of Science, Technology and Innovation, Denmark, Aarhus University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00497185
Brief Title
Mindfulness-based Cognitive Therapy for Patients With Functional Disorders
Official Title
Mindfulness-based Cognitive Therapy for Patients With Functional Disorders. A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
June 2007 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
June 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
The Ministry of Science, Technology and Innovation, Denmark, Aarhus University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to examine the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) in patients with functional disorders defined as severe Bodily Distress Disorder.
Hypothesis: MBCT can ameliorate the symptoms of FD defined as severe Bodily Distress Disorder and decrease health care utilization beyond the effect of shared care. Patients treated with MBCT will function better physically and socially than patients treated with shared care at 12 months' follow-up.
Detailed Description
Functional Disorders (FD) are conditions where patients complain of multiple medically unexplained physical symptoms. FD defy the clinical picture of any conventionally defined disease and cannot adequately be supported by clinical or para-clinical findings. The disorders are common in all medical settings, both in primary and secondary care. The conditions range from mild to severe and disabling, they are costly for society due to the patients' high health care use, and the patients' social and functional level is reduced. There is no well-established, effective pharmacological, or psychotherapeutical treatment offer today.
In randomized controlled trials, cognitive behavioural treatment has shown to be effective for selected patient groups suffering from FD. However, only a few trials have been made, especially concerning treatment of the most severe disorders.
Randomized controlled trials on Mindfulness-Based Stress Reduction (MBSR) have shown mitigation of stress, anxiety, and dysphoria in a general population sample and reduction in total mood disturbances and stress symptoms in a medical population sample. Furthermore, RCTs in Mindfulness-Based Cognitive Therapy (MBCT) have demonstrated a 50 % reduction of depression relapse for individuals, who have experienced three or more previous episodes.
We wish to examine the efficacy of MBCT in patients with functional disorders defined as severe Bodily Distress Disorder.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Somatization Disorder, Functional Disorders, Bodily Distress Disorder
Keywords
Mindfulness-Based Cognitive Therapy, Somatization Disorder, Medically Unexplained Symptoms, Functional Somatic Symptoms, SF-36
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Other
Arm Description
Mindfulness-Based Cognitive Therapy
Arm Title
B
Arm Type
No Intervention
Arm Description
Shared care: Treatment as usual augmented by psychiatric consultation intervention to optimise treatment in the present health care system.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness-Based Cognitive Therapy for Functional Disorders
Intervention Description
Mindfulness-based cognitive therapy: A manualized program will be delivered by two instructors who are experienced cognitive therapists in eight weekly 3½-hour group training sessions and one follow-up session after a month involving up to 12 patients with somatoform disorders. The patients must be willing and able to attend and devote up to 1 hour per day for homework.
The therapy is compared with a group of controls receiving shared care defined as: Treatment as usual augmented by psychiatric consultation intervention: The patients are offered a psychiatric consultation after the assessment interview. It is the aim to optimise treatment in the present health care system.
Primary Outcome Measure Information:
Title
Physical health measured by SF-36 Physical Component Summary
Time Frame
End of treatment, 6 and 12 months' follow-up
Secondary Outcome Measure Information:
Title
1. Social functioning, emotional disorders, coping: Sub-scales from SF-36, WHO-DAS II, CSQ, SCL, Whiteley-7, lifestyle factors, mindfulness scales. 2. Health care use: Data from national registers.
Time Frame
End of treatment, 6 and 12 months' follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Functional disorder defined as Bodily Distress Disorder, severe
Moderate to severe impairment
The disorder's functional component can easily be separated from a coexisting well-defined physical disease
No lifetime-diagnosis of psychosis, bipolar affective disorder, or depression with psychotic symptoms
Age 20-50 years
Patients of Scandinavian origin, who understand, read, write, and speak Danish
Exclusion Criteria:
No informed consent
An acute psychiatric disorder demanding other treatment, or if the patient is suicidal
Abuse of narcotics or alcohol or (non-prescribed) medicine
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Per Fink, DMSc
Organizational Affiliation
The Research Clinic for Functional Disorders, Aarhus University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Per Fink
City
Aarhus C
ZIP/Postal Code
8000
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Mindfulness-based Cognitive Therapy for Patients With Functional Disorders
We'll reach out to this number within 24 hrs